Aflibercept (Localization)
Not specified (typically ophthalmology, oncology)
Not specifiedActive
Key Facts
Indication
Not specified (typically ophthalmology, oncology)
Phase
Not specified
Status
Active
Company
About Pharmapark
Pharmapark is a private, revenue-generating Russian biopharmaceutical company established in 2003, operating as a full-cycle developer and manufacturer of biological drugs. It has a diversified business model combining proprietary in-house product development with extensive contract manufacturing and localization services for international partners. The company's strategy leverages its GMP-certified production facilities, R&D center, and a network of global partnerships to bring both generic and original biologics to the Russian market and beyond.
View full company profile